Investigational Drug Prevents Flu-induced Lung Injury
UH15-38 shows potential in preventing lung injury and reducing inflammation in severe influenza when administered even five days after infection.
UH15-38 shows potential in preventing lung injury and reducing inflammation in severe influenza when administered even five days after infection.
While current approaches target the virus, a new study demonstrates that treating the host to prevent them from transmitting the virus to another host could be a potential new strategy for flu prevention.
The first participant has been dosed in a Phase 3 study of Moderna's Flu-COVID vaccine candidate (mRNA-1083) in the US, according to the company.
A year after discovering that flu vaccines decrease the risk of Alzheimer’s disease by 40%, the same research team found that several other common vaccines also provide protective benefits.
Read MoreResearchers demonstrated in mice that molecules in certain vegetables help to maintain a healthy barrier in the lungs and ease infection during illness.
Read MoreScientists are providing one of the first snapshots of the interplay among these three common but potentially deadly viruses.
Read MoreA notable signal of protection of 84% was observed against symptomatic influenza infection in a phase 2a study.
Read MoreAltered B cell function in children with mitochondrial disorders led to a weaker and less diverse antibody response to viral infections, according to NIH researchers.
Read MoreNew research reveals how cleaner air kills airborne viruses significantly quicker and why opening a window may be more important than originally thought.
Read MoreA study involving over 600,000 participants revealed a significantly elevated risk of respiratory infection among individuals diagnosed with insomnia.
Read MoreA team from the University of Geneva has identified how the influenza A virus manages to penetrate cells to infect them.
Read MoreRegular aerobic exercise is tied to a significantly lower risk of death from flu or pneumonia, even at levels below those recommended, according to a new study.
Read MoreThe phase 1 trial will test the experimental vaccine, known as H1ssF-3928 mRNA-LNP, for safety and its ability to induce an immune response.
Read MoreA phase 1 clinical trial will test an experimental mRNA universal influenza vaccine known as H1ssF-3928 mRNA-LNP.
Read MoreInhaling low concentrations of ethanol vapor can disable the influenza A virus in mice, say scientists. They believe it may also treat similar viruses, such as the one that causes COVID-19.
Read More